COMPARISON OF HEALTHCARE COSTS OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSTION WITH PHOSPHODIESTERASE-5 INHIBITOR FAILURE WHO SWITCHED TO RIOCIGUAT VS THOSE WHO AUGMENTED THERAPY
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI